Rotor-based image-guided therapy of glioblastoma

J Control Release. 2024 Apr:368:650-662. doi: 10.1016/j.jconrel.2024.03.020. Epub 2024 Mar 18.

Abstract

Glioblastoma (GBM), deep in the brain, is more challenging to diagnose and treat than other tumors. Such challenges have blocked the development of high-impact therapeutic approaches that combine reliable diagnosis with targeted therapy. Herein, effective cyanine dyes (IRLy) with the near-infrared two region (NIR-II) adsorption and aggregation-induced emission (AIE) have been developed via an "extended conjugation & molecular rotor" strategy for multimodal imaging and phototherapy of deep orthotopic GBM. IRLy was synthesized successfully through a rational molecular rotor modification with stronger penetration, higher signal-to-noise ratio, and a high photothermal conversion efficiency (PCE) up to ∼60%, which can achieve efficient NIR-II photo-response. The multifunctional nanoparticles (Tf-IRLy NPs) were further fabricated to cross the blood-brain barrier (BBB) introducing transferrin (Tf) as a targeting ligand. Tf-IRLy NPs showed high biosafety and good tumor enrichment for GBM in vitro and in vivo, and thus enabled accurate, efficient, and less invasive NIR-II multimodal imaging and photothermal therapy. This versatile Tf-IRLy nanosystem can provide a reference for the efficient, precise and low-invasive multi-synergistic brain targeted photo-theranostics. In addition, the "extended conjugation & molecular rotor" strategy can be used to guide the design of other photothermal agents.

Keywords: Cyanine dye; Glioblastoma; Multimodal imaging; NIR-II; Photothermal therapy.

MeSH terms

  • Blood-Brain Barrier
  • Brain
  • Cell Line, Tumor
  • Coloring Agents
  • Glioblastoma* / diagnostic imaging
  • Glioblastoma* / therapy
  • Humans
  • Nanoparticles* / therapeutic use
  • Neoplasms*
  • Phototherapy / methods
  • Theranostic Nanomedicine / methods

Substances

  • Coloring Agents